Insulin Pump Class: Back to the Basics of Pump Therapy.
作者信息
Reece Sara Wilson, Hamby Williams Cheryl Lynn
出版信息
Diabetes Spectr. 2014 May;27(2):135-40. doi: 10.2337/diaspect.27.2.135.
Abstract
摘要
相似文献
1
Insulin Pump Class: Back to the Basics of Pump Therapy.胰岛素泵课程：回归泵治疗的基础
Diabetes Spectr. 2014 May;27(2):135-40. doi: 10.2337/diaspect.27.2.135.
2
An Expert Opinion on Advanced Insulin Pump Use in Youth with Type 1 Diabetes.专家意见：青少年 1 型糖尿病患者使用先进胰岛素泵的相关问题。
Diabetes Technol Ther. 2017 Mar;19(3):145-154. doi: 10.1089/dia.2016.0354. Epub 2017 Jan 30.
3
The Use of Technology in Managing Diabetes in Youth Part 2-Insulin Pump Technologies: Information and Tips for the School Nurse.青少年糖尿病管理中的技术应用 第 2 部分-胰岛素泵技术：学校护士的信息和建议。
NASN Sch Nurse. 2020 Jul;35(4):188-195. doi: 10.1177/1942602X20928914. Epub 2020 Jun 2.
4
Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus.
Am J Obstet Gynecol. 2000 Jun;182(6):1283-91. doi: 10.1067/mob.2000.106182.
5
Insulin pump-associated adverse events are common, but not associated with glycemic control, socio-economic status, or pump/infusion set type.胰岛素泵相关不良事件很常见，但与血糖控制、社会经济状况或泵/输液器类型无关。
Acta Diabetol. 2016 Dec;53(6):991-998. doi: 10.1007/s00592-016-0897-2. Epub 2016 Sep 1.
6
Continuous subcutaneous insulin infusion: practical issues.持续皮下胰岛素输注：实际问题
Indian J Endocrinol Metab. 2012 Dec;16(Suppl 2):S259-62. doi: 10.4103/2230-8210.104055.
7
Will long acting insulin analogs influence the use of insulin pump therapy in type 1 diabetes?
Curr Diabetes Rev. 2005 Feb;1(1):23-6. doi: 10.2174/1573399052952659.
8
The durability and effectiveness of sensor-augmented insulin pump therapy in pediatric and young adult patients with type 1 diabetes.传感器增强型胰岛素泵治疗在1型糖尿病儿童及年轻成人患者中的耐用性和有效性。
Ann Pediatr Endocrinol Metab. 2020 Dec;25(4):248-255. doi: 10.6065/apem.2040048.024. Epub 2020 Dec 31.
9
Impact of insulin pump therapy on glycemic control among adult Saudi type-1 diabetic patients. An interview-based case-control study.胰岛素泵治疗对沙特成年1型糖尿病患者血糖控制的影响。一项基于访谈的病例对照研究。
J Family Med Prim Care. 2020 Feb 28;9(2):1013-1019. doi: 10.4103/jfmpc.jfmpc_869_19. eCollection 2020 Feb.
10
Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group.使用植入式胰岛素泵对胰岛素依赖型糖尿病进行长期治疗。植入式胰岛素泵试验研究组。
Diabetes Care. 1997 Jan;20(1):59-63. doi: 10.2337/diacare.20.1.59.
引用本文的文献
1
Development and validation of an instrument (CSII - Brazil) to assess users' conceptual and procedural knowledge of continuous subcutaneous infusion systems.开发和验证一种评估用户对连续皮下输注系统的概念和程序知识的工具（CSII - 巴西）。
Arch Endocrinol Metab. 2021 Nov 1;65(1):67-78. doi: 10.20945/2359-3997000000314. Epub 2020 Dec 15.
本文引用的文献
1
Insulin pumps.
Diabetes Forecast. 2012 Jan;65(1):50-3.
2
Patient-reported outcomes and diabetes technology: a systematic review of the literature.患者报告的结局与糖尿病技术：文献系统综述
Pediatr Endocrinol Rev. 2010 Aug;7 Suppl 3:405-12.
3
Insulin pump therapy: guidelines for successful outcomes.胰岛素泵治疗：成功治疗的指南
Diabetes Educ. 2009 Mar-Apr;35 Suppl 2:29S-41S; quiz 28S, 42S-43S. doi: 10.1177/0145721709333493.
4
Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years.持续皮下胰岛素输注（CSII）与多次皮下注射（MDI）用于儿童1型糖尿病的比较：一项为期3年的多中心配对队列分析
Diabet Med. 2008 Jan;25(1):80-5. doi: 10.1111/j.1464-5491.2007.02311.x.
5
Treating the spectrum of type 2 diabetes: emphasis on insulin pump therapy.
Diabetes Educ. 2006 Jan-Feb;32(1 Suppl):39S-46S. doi: 10.1177/0145721705285642.
6
Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial.持续皮下胰岛素输注（CSII）与基于中效胰岛素的多次每日胰岛素注射（MDI）对血糖控制及生活质量影响的比较：五国试验结果
Diabet Med. 2006 Feb;23(2):141-7. doi: 10.1111/j.1464-5491.2005.01738.x.
7
Use of continuous subcutaneous insulin infusion pump in patients with type 2 diabetes mellitus.
Diabetes Educ. 2005 Nov-Dec;31(6):843-8. doi: 10.1177/0145721705283078.
8
Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.门冬胰岛素持续皮下输注（CSII）与门冬胰岛素/甘精胰岛素多次皮下注射用于既往接受CSII治疗的1型糖尿病患者的比较
Diabetes Care. 2005 Mar;28(3):533-8. doi: 10.2337/diacare.28.3.533.
9
A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.一项比较持续皮下胰岛素输注与使用甘精胰岛素多次每日注射疗效的随机前瞻性试验。
Diabetes Care. 2004 Jul;27(7):1554-8. doi: 10.2337/diacare.27.7.1554.
10
Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.持续皮下胰岛素输注与每日多次注射疗法治疗2型糖尿病同样有效：一项随机、平行组、为期24周的研究。
Diabetes Care. 2003 Sep;26(9):2598-603. doi: 10.2337/diacare.26.9.2598.
Zotero 插件